Skip to main content

Advertisement

Table 2 Therapy characteristics and disease outcome

From: Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Characteristic N (%) Characteristic N (%)
Type of breast surgery   Disease relapse  
Radical mastectomy 36 (44.44) Yes 10 (12.35)
Breast conserving surgery 41 (50.62) No 71 (87.65)
Other 4 (4.94)   
   First relapse site  
   Locoregional relapse 4 (4.94)
Adjuvant systemic therapy   Lung 3 (3.7)
Yes 81 (100) Liver 1 (1.23)
No Bones 4 (4.94)
   Brain 1 (1.23)
   Contralateral BC 1 (1.23)
Adjuvant hormonal therapy 81 (100) Total 10 (12.35)
TAM 70 (86.42)   
TAM + GOSERELIN 2 (2.47) Patients’ outcome  
AI 9 (11.11) Dead 7 (8.64)
   Alive 74 (91.36)
Adjuvant RT   Relevant events a  
Yes 45 (55.56) Yes 15 (18.52)
No 36 (44.44) No 66 (81.48)
  1. aRelevant events: development of loco-regional recurrence and/or distant metastases and/or contralateral breast cancer and/or non-breast primary cancer and/or death from any cause